NYSE:ELVHealthcare
Elevance Health (ELV) Stock Faces Margin Squeeze As Q2 Profitability Trails Bullish Narratives
Elevance Health (ELV) has released its Q2 2026 numbers, reporting revenue of about US$50.5b, basic EPS of US$6.71 and net income of US$1,463m. The trailing twelve months show revenue of roughly US$201.1b, EPS of US$22.53 and net income of US$4,963m. Over recent quarters the company has seen revenue move from US$49.8b in Q2 2025 to US$50.5b in Q2 2026. Over the same period, quarterly basic EPS shifted from US$7.74 to US$6.71 and net income from US$1,743m to US$1,463m, setting the backdrop for...